Humana Shares Dip as Earnings Disappoint vs. Peers, Plans to Exit 600K Member Plans
HUM has more than doubled off its 52-week low of $163.11.
Summary
Humana's Q2 adjusted EPS of $7.61 beat estimates but failed to impress investors, sending shares lower in morning trading. The disappointment stems from a lack of upward guidance revision, contrasting with peers like UnitedHealth that raised forecasts on lower Medicare cost trends. Adding pressure, Humana announced plans to exit Medicare plans covering roughly 600,000 members next year to focus on margins. CEO Jim Rechtin also flagged that the end of a Medicare drug plan subsidy will hit members more than the company. The stock's decline reflects a reset of expectations after a strong run, with analysts noting the market wanted more upside. Watch for further details on the plan exits and margin impact in upcoming quarters.
At the time of this announcement, HUM was trading at $358.92 on NYSE in the Trade & Services sector, with a market capitalization of approximately $43.1B. The 52-week trading range was $163.11 to $428.88. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.